Fusion Pharmaceuticals logo

Fusion Pharmaceuticals

Biotechnology company using alpha particle emitting medical isotopes in targeted radiotherapy for cancer.

3

Funding Rounds

$151.0m

Money raised

Overview

Biotechnology company using alpha particle emitting medical isotopes in targeted radiotherapy for cancer.

Funding series

Funding Series Analysis

The company Fusion Pharmaceuticals has raised a total of $25m in funding over 3 rounds.

Key Insights:

  • Fusion Pharmaceuticals Series A round, February 2017: $25m
  • Fusion Pharmaceuticals funding round, September 2017: $21m
  • Fusion Pharmaceuticals funding round, April 2019: $105m
Fusion Pharmaceuticals logo
Fusion Pharmaceuticals Series A round, February 2017 $25m
Fusion Pharmaceuticals logo
Fusion Pharmaceuticals funding round, September 2017 $21m
Fusion Pharmaceuticals logo
Fusion Pharmaceuticals funding round, April 2019 $105m

Industries

Fusion Pharmaceuticals is active in the following industries:
  • Biomedical engineering
  • Oncology
  • Therapy
  • Cancer
  • Chemistry
  • ADME
  • Drug metabolism
  • Enzyme kinetics
  • Pharmacokinetics
  • Technology
  • Biology
  • Biotechnology
  • Internal medicine
  • Healthcare
  • Medicine
  • Engineering